About CIDRAP | CIDRAP
The Center for Infectious Disease Research and Policy (CIDRAP; "SID-wrap") is a global leader in addressing public health preparedness and emerging infectious disease response. Founded in 2001, CIDRAP is part of the Research and Innovation Office at the University of Minnesota. CIDRAP works to ...
Osterholm Update - CIDRAP
Nov 14, 2024 · In "Better Times," Dr. Osterholm and Chris Dall discuss the latest COVID, H5N1, and seasonal influenza data. Dr. Osterholm also answers an ID query on the ideal timing for COVID-19 booster doses and an ID query about Marburg virus transmission.
Infectious Disease Topics A-Z - CIDRAP
A comprehensive list of infectious diseases that CIDRAP covers. Our site is an authoritative, reliable, and timely source of science-based information about global, emerging infectious diseases.
Study describes rise in severe Shigella infections in Vancouver
19 hours ago · A study in Vancouver found an increase in severe, multidrug-resistant (MDR) shigellosis cases and a shift in patient demographics, researchers reported yesterday in Clinical Infectious Diseases.. For the study, a team of researchers from the University of British Columbia conducted a retrospective review of 163 patients diagnosed as having Shigella sonnei infections from 2015 through 2022.
Antiviral COVID-19 drug molnupiravir tied to large drop in
1 day ago · When given early, the antiviral drug molnupiravir (Lagevrio) halved the risk of COVID-19 death and reduced all-cause deaths among older adults in the Czech Republic in 2022, findings published yesterday in Open Forum Infectious Diseases suggest. Masaryk University researchers analyzed data from all 74,541 adults with a diagnosis of COVID-19 in the national registry infection treated with ...
Our Projects - CIDRAP
The Centers of Excellence for Influenza Research and Surveillance (CEIRS) Network Pandemic Research Response Planning project is a cross-center collaborative initiative aimed at enhancing the CEIRS network’s ability to mobilize its scientific expertise and capabilities during an influenza pandemic or pre-pandemic situation and provide research-based knowledge to inform the U.S. Department of ...
Novel genomic test shows promise to streamline diagnosis of …
2 days ago · After a decade in development, a new genomic test developed at the University of California–San Francisco (UCSF) promises to rapidly and accurately diagnosis infections caused by almost any pathogen—whether a virus, bacterium, fungus, or parasite. The tool uses a genomic sequencing technique ...
CIDRAP in the News
Oct 27, 2024 Advancing influenza vaccines: A review of next-generation candidates and their potential for global health impact paper published in Vaccine is co-authored by Julie Ostrowsky, MSc, et al.. Oct 11, 2024 CIDRAP announces that it has received funding from the Coalition for Epidemic Preparedness Innovations (CEPI) to advance its open-access Coronavirus Vaccines Research and ...
Episode 148: No Time to Quit - CIDRAP
Jan 11, 2024 · In "No Time to Quit," Dr. Osterholm and Chris Dall discuss the JN.1 variant, Paxlovid uptake, and COVID-19 vaccine disinformation. Dr. Osterholm also provides an update on influenza and RSV transmission and shares the latest "This Week in Public Health History" segment. Opinion: The U.S. is facing the biggest COVID wave since Omicron. Why are we still playing make-believe?
Episode 157: Lungs & Udders - CIDRAP
May 16, 2024 · In "Lungs & Udders," Dr. Osterholm provides updates on H5N1 influenza, COVID-19, and mpox. He also shares his thoughts on a recent WHO report about airborne transmission and a study on the use of a diabetes drug to treat COVID-19. Airborne pathogens: controlling words won’t control transmission (Greenhalgh et al., The Lancet) Sign up for CIDRAP's daily newsletter MORE EPISODES SUPPORT THIS ...
- Some results have been removed